Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
World Journal of Surgery
Erschienen in: World Journal of Surgery 10/2021

21.06.2021 | Original Scientific Report

Prognostic Significance of Preoperative Osteopenia in Patients Undergoing Esophagectomy for Esophageal Cancer

verfasst von: Keita Takahashi, Katsunori Nishikawa, Kenei Furukawa, Yuichiro Tanishima, Yoshitaka Ishikawa, Takanori Kurogochi, Masami Yuda, Yujiro Tanaka, Akira Matsumoto, Norio Mitsumori, Toru Ikegami

Erschienen in: World Journal of Surgery | Ausgabe 10/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Osteopenia, which exhibits low bone mineral density (BMD), has been linked to sarcopenia and recently reported as a prognostic factor in various cancers. However, the prognostic significance of osteopenia in esophageal cancer remains unclear. Hence, this study aimed to clarify the impact of osteopenia on the prognosis of patients undergoing esophagectomy for esophageal cancer.

Methods

We included 229 patients who underwent esophagectomy. BMD was calculated as the average pixel density (Hounsfield unit) within a circle in midvertebral core at the 11th thoracic vertebra on preoperative computed tomography. We then divided the patients into the Osteopenia group (n = 159) and the Non-Osteopenia group (n = 70) according to the optimal cutoff value obtained from the receiver operating characteristic curve. Their clinicopathological data, prognosis, and recurrence were analyzed.

Results

The mean age was significantly older in the Osteopenia group (p = 0.047). The Osteopenia group had significantly worse overall survival (OS) and relapse-free survival (RFS) than the Non-Osteopenia group (p = 0.001 and p = 0.012, respectively). Multivariate analysis revealed osteopenia was an independent prognostic factor for OS (p < 0.001; hazard ratio [HR], 2.243; 95% confidence interval [CI], 1.422–3.538) and RFS (p = 0.008; HR, 1.739; 95% CI, 1.154–2.620). In logistic regression model, advanced age and cStage III-IV were independent risk factors for preoperative osteopenia.

Conclusions

Preoperative osteopenia is associated with poor survival and recurrence in patients undergoing esophagectomy for esophageal cancer.
Literatur
1.
Napier KJ, Scheerer M, Misra S (2014) Esophageal cancer: a review of epidemiology, pathogenesis, staging workup and treatment modalities. World J gastrointest oncol 6:112–120PubMedPubMedCentralCrossRef
2.
Fujita H, Kakegawa T, Yamana H et al (1995) Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg 222:654–662PubMedPubMedCentralCrossRef
3.
Takeuchi H, Miyata H, Gotoh M et al (2014) A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database. Ann Surg 260:259–266PubMedCrossRef
4.
Mariette C, Piessen G, Triboulet JP (2007) Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol 8:545–553PubMedCrossRef
5.
Baba Y, Yoshida N, Shigaki H et al (2016) Prognostic impact of postoperative complications in 502 patients with surgically resected esophageal squamous cell carcinoma: a retrospective single-institution study. Ann Surg 264:305–311PubMedCrossRef
6.
Saeki H, Tsutsumi S, Tajiri H et al (2017) Prognostic significance of postoperative complications after curative resection for patients with esophageal squamous cell carcinoma. Ann Surg 265:527–533PubMedCrossRef
7.
Verschueren S, Gielen E, O’Neill TW et al (2013) Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men. Osteoporos Int J Established Result Cooperation Between Eur Found Osteoporos National Osteoporos Found USA 24:87–98CrossRef
8.
Seeman E, Hopper JL, Young NR et al (1996) Do genetic factors explain associations between muscle strength, lean mass, and bone density? A twin study. Am J Physiol 270:E320-327PubMed
9.
Blain H, Jaussent A, Thomas E et al (2010) Appendicular skeletal muscle mass is the strongest independent factor associated with femoral neck bone mineral density in adult and older men. Exp Gerontol 45:679–684PubMedCrossRef
10.
Coin A, Perissinotto E, Enzi G et al (2008) Predictors of low bone mineral density in the elderly: the role of dietary intake, nutritional status and sarcopenia. Eur J Clin Nutr 62:802–809PubMedCrossRef
11.
12.
Nakashima Y, Saeki H, Nakanishi R et al (2018) Assessment of sarcopenia as a predictor of poor outcomes after esophagectomy in elderly patients with esophageal cancer. Ann Surg 267:1100–1104PubMedCrossRef
13.
Takahashi K, Watanabe M, Kozuki R et al (2019) Prognostic significance of skeletal muscle loss during early postoperative period in elderly patients with esophageal cancer. Ann Surg Oncol 26:3727–3735PubMedCrossRef
14.
Martin L, Birdsell L, Macdonald N et al (2013) Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol Offi J Am Soc Clin Oncol 31:1539–1547CrossRef
15.
Prado CM, Lieffers JR, McCargar LJ et al (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9:629–635PubMedCrossRef
16.
Harimoto N, Shirabe K, Yamashita YI et al (2013) Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg 100:1523–1530PubMedCrossRef
17.
Sharma P, Parikh ND, Yu J et al (2016) Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc 22:1092–1098
18.
Motomura T, Uchiyama H, Iguchi T et al (2020) Impact of osteopenia on oncologic outcomes after curative resection for pancreatic cancer. vivo Athens Greece 34:3551–3557
19.
20.
Yao S, Kaido T, Okumura S et al (2019) Bone mineral density correlates with survival after resection of extrahepatic biliary malignancies. Clin Nutr (Edinburgh, Scotland) 38:2770–2777CrossRef
21.
Sobin LH, Compton CC (2010) TNM seventh edition: what’s new, what’s changed: communication from the international union against cancer and the American joint committee on cancer. Cancer 116:5336–5339PubMedCrossRef
22.
Kanda Y (2013) Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant 48:452–458PubMedCrossRef
23.
Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ (Clin Res ed) 312:1254–1259CrossRef
24.
Cosman F, de Beur SJ, LeBoff MS et al (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int J Establ Result Cooperation Between Eur Found Osteoporos National Osteoporos Found USA 25:2359–2381CrossRef
25.
Pickhardt PJ, Pooler BD, Lauder T et al (2013) Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications. Ann Intern Med 158:588–595PubMedPubMedCentralCrossRef
26.
Toshima T, Yoshizumi T, Ikegami T et al (2018) Impact of osteopenia in liver cirrhosis: special reference to standard bone mineral density with age. Anticancer Res 38:6465–6471PubMedCrossRef
27.
28.
Lumachi F, Basso SMM, Camozzi V et al (2018) Bone mineral density as a potential predictive factor for luminal-type breast cancer in postmenopausal women. Anticancer Res 38:3049–3054PubMed
29.
Rosario M, Takeuchi A, Yamamoto N et al (2017) Pathogenesis of osteosclerotic change following treatment with an antibody against RANKL for giant cell tumour of the bone. Anticancer Res 37:749–754PubMedCrossRef
30.
Pluijm SM, Visser M, Smit JH et al (2001) Determinants of bone mineral density in older men and women: body composition as mediator. J Bone Miner Res Off J American Soc Bone Miner Res 16:2142–2151CrossRef
31.
Furukawa K, Haruki K, Taniai T et al (2021) Osteosarcopenia is a potential predictor for the prognosis of patients who underwent hepatic resection for colorectal liver metastases. Ann Gastroenterol Surg 5(3):390–398PubMedPubMedCentralCrossRef
32.
33.
Chen CW, Tsai HL, Yeh YS et al (2013) Osteoporosis self-assessment tool for Asians as a simple risk index of identifying a poor prognosis in women surgically treated for colorectal cancer. J Surg Res 181:242–249PubMedCrossRef
34.
Ramin C, May BJ, Roden RBS et al (2018) Evaluation of osteopenia and osteoporosis in younger breast cancer survivors compared with cancer-free women: a prospective cohort study. Breast Cancer Res BCR 20:134PubMedCrossRef
35.
Jones DH, Nakashima T, Sanchez OH et al (2006) Regulation of cancer cell migration and bone metastasis by RANKL. Nature 440:692–696PubMedCrossRef
36.
Morony S, Capparelli C, Sarosi I et al (2001) Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis. Can Res 61:4432–4436
37.
Roodman GD, Dougall WC (2008) RANK ligand as a therapeutic target for bone metastases and multiple myeloma. Cancer Treat Rev 34:92–101PubMedCrossRef
38.
Calvi LM, Adams GB, Weibrecht KW et al (2003) Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425:841–846PubMedCrossRef
39.
Loser K, Mehling A, Loeser S et al (2006) Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat Med 12:1372–1379PubMedCrossRef
40.
Yamada D, Eguchi H, Iwagami Y et al (2017) Patients treated with preoperative chemoradiation for pancreatic ductal adenocarcinoma have impaired bone density, a predictor of distant metastasis. Ann Surg Oncol 24:3715–3724PubMedCrossRef
41.
Deeb KK, Trump DL, Johnson CS (2007) Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 7:684–700PubMedCrossRef
42.
Müller K, Odum N, Bendtzen K (1993) 1,25-dihydroxyvitamin D3 selectively reduces interleukin-2 levels and proliferation of human T cell lines in vitro. Immunol Lett 35:177–182PubMedCrossRef
43.
Gurlek A, Pittelkow MR, Kumar R (2002) Modulation of growth factor/cytokine synthesis and signaling by 1alpha,25-dihydroxyvitamin D(3): implications in cell growth and differentiation. Endocr Rev 23:763–786PubMedCrossRef
44.
Zhou W, Heist RS, Liu G et al (2007) Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol Off J Am Soc Clinical Oncol 25:479–485CrossRef
45.
Akiba T, Morikawa T, Odaka M et al (2018) Vitamin D supplementation and survival of patients with non-small cell lung cancer: a randomized, double-blind, placebo-controlled trial. Clin Cancer Res Off J Am Assoc Cancer Res 24:4089–4097CrossRef
46.
Ng K, Meyerhardt JA, Wu K et al (2008) Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol Off J Am Soc Clinoncol 26:2984–2991CrossRef
Metadaten
Titel
Prognostic Significance of Preoperative Osteopenia in Patients Undergoing Esophagectomy for Esophageal Cancer
verfasst von
Keita Takahashi
Katsunori Nishikawa
Kenei Furukawa
Yuichiro Tanishima
Yoshitaka Ishikawa
Takanori Kurogochi
Masami Yuda
Yujiro Tanaka
Akira Matsumoto
Norio Mitsumori
Toru Ikegami
Publikationsdatum
21.06.2021
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 10/2021
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-021-06199-w

Weitere Artikel der Ausgabe 10/2021

World Journal of Surgery 10/2021 Zur Ausgabe

Surgery in Low and Middle Income Countries

Delivering Essential Surgical Care for Lower-limb Musculoskeletal disorders in the Low-Resource Setting

Original Scientific Report

Laparoscopic Sleeve Gastrectomy has A Positive Impact on Subclinical Hypothyroidism Among Obese Patients: A Prospective Study

Original Scientific Report

Impact of 2016 Enhanced Recovery After Surgery (ERAS) Recommendations on Outcomes after Hepatectomy in Cirrhotic and Non-Cirrhotic Patients

Surgery in Low and Middle Income Countries

A South American Experience With Postoperative Complications Following Chest Wall Reconstruction for Neoplasms

Original Scientific Report

The Impact of Aberrant Hepatic Artery on Resection Margin and Outcomes of Laparoscopic Pancreatoduodenectomy: A Single-Center Report

Scientific Review

Postoperative Pain Relief after Pancreatic Resection: Systematic Review and Meta-Analysis of Analgesic Modalities

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich

17.04.2024 | Postoperative nausea and vomiting | Nachrichten

Hochrisiko-Eingriffe für postoperative Übelkeit

weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.